HomeCompareGLWLF vs MRK

GLWLF vs MRK: Dividend Comparison 2026

GLWLF yields 4878.05% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GLWLF wins by $48953635367862.14M in total portfolio value
10 years
GLWLF
GLWLF
● Live price
4878.05%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$48953635367862.20M
Annual income
$47,056,025,708,614,450,000.00
Full GLWLF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GLWLF vs MRK

📍 GLWLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGLWLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GLWLF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GLWLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLWLF
Annual income on $10K today (after 15% tax)
$414,634.15/yr
After 10yr DRIP, annual income (after tax)
$39,997,621,852,322,280,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GLWLF beats the other by $39,997,621,852,322,275,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLWLF + MRK for your $10,000?

GLWLF: 50%MRK: 50%
100% MRK50/50100% GLWLF
Portfolio after 10yr
$24476817683931.13M
Annual income
$23,528,012,854,307,230,000.00/yr
Blended yield
96.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GLWLF
No analyst data
Altman Z
-3.2
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLWLF buys
0
MRK buys
0
No recent congressional trades found for GLWLF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGLWLFMRK
Forward yield4878.05%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$48953635367862.20M$56.8K
Annual income after 10y$47,056,025,708,614,450,000.00$9,798.13
Total dividends collected$48825140738705.46M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GLWLF vs MRK ($10,000, DRIP)

YearGLWLF PortfolioGLWLF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$498,505$487,804.88$11,206$366.19+$487.3KGLWLF
2$23,259,859$22,726,458.99$12,650$502.35+$23.25MGLWLF
3$1,015,915,457$991,027,407.41$14,407$694.19+$1015.90MGLWLF
4$41,540,182,244$40,453,152,705.37$16,585$967.82+$41540.17MGLWLF
5$1,590,340,977,519$1,545,892,982,517.95$19,342$1,363.89+$1590340.96MGLWLF
6$57,013,427,657,541$55,311,762,811,595.47$22,913$1,947.19+$57013427.63MGLWLF
7$1,914,197,254,068,091$1,853,192,886,474,521.50$27,662$2,823.89+$1914197254.04MGLWLF
8$60,197,744,519,759,976$58,149,553,457,907,120.00$34,159$4,173.35+$60197744519.73MGLWLF
9$1,773,466,971,259,579,400$1,709,055,384,623,436,000.00$43,337$6,308.80+$1773466971259.54MGLWLF
10$48,953,635,367,862,200,000$47,056,025,708,614,450,000.00$56,776$9,798.13+$48953635367862.14MGLWLF

GLWLF vs MRK: Complete Analysis 2026

GLWLFStock

Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America. The company engages in the commercialization of two technologies, such as MyCell Enhanced technology, a nutraceutical and cannabis nutrient delivery technology; and a cannabis Smart Consumption System to assist users and patients to store, journal, control, consume, and manage cannabis related products. The company has the exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K, and iron. It also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company was incorporated in 2018 and is based in Toronto, Canada.

Full GLWLF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GLWLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLWLF vs SCHDGLWLF vs JEPIGLWLF vs OGLWLF vs KOGLWLF vs MAINGLWLF vs JNJGLWLF vs ABBVGLWLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.